Reconstituted high-density lipoprotein can elevate plasma alanine aminotransferase by transient depletion of hepatic cholesterol: role of the phospholipid component

CSL112 Enhances Biomarkers of Reverse Cholesterol Transport After Single and Multiple Infusions in Healthy Subjects

(2014) Andreas Gille et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

(2014) Anand Rohatgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel Formulation of a Reconstituted High-Density Lipoprotein (CSL112) Dramatically Enhances ABCA1-Dependent Cholesterol Efflux

(2013) Svetlana Diditchenko et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Reconstituted HDL for the acute treatment of acute coronary syndrome

(2013) Brian R. Krause et al.   CURRENT OPINION IN LIPIDOLOGY

A multiple ascending dose study of CSL112, an infused formulation of ApoA-I

(2013) Rachael Easton et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Cholesterol Efflux and Atheroprotection

(2012) Robert S. Rosenson et al.   CIRCULATION

Pharmacologic Suppression of Hepatic ATP-Binding Cassette Transporter 1 Activity in Mice Reduces High-Density Lipoprotein Cholesterol Levels but Promotes Reverse Cholesterol Transport

(2011) Shigenori Yamamoto et al.   CIRCULATION

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathways by Which Reconstituted High-Density Lipoprotein Mobilizes Free Cholesterol From Whole Body and From Macrophages

(2009) Marina Cuchel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-density lipoprotein/apolipoprotein A-I infusion therapy

(2008) Jean-Claude Tardif et al.   Current Atherosclerosis Reports

Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol

(2008) Yvonne Lange et al.   PROGRESS IN LIPID RESEARCH